Next‑generation metabolomics: From annotation to discovery at scale
Advances in metabolomics and lipidomics are generating unprecedented volumes of complex data, but confident identification and biological interpretation of small molecules remain significant challenges. Limitations in annotation, data dimensionality, and reproducibility can slow discovery and reduce confidence in downstream decision‑making across clinical, translational, and applied research.
In this live broadcast event, leading experts explore how next‑generation mass spectrometry technologies, ion mobility, isotope‑based filtering, and computational tools are helping researchers move from complex datasets to confident insight. Through two short, focused scientific talks, speakers will share real‑world examples of how multi‑dimensional data and advanced workflows are being used to improve metabolite and lipid annotation, accelerate small‑molecule discovery, and enable more robust and reproducible analyses.
Broadcast as a single, high‑impact session and presented in partnership with Bruker, this webinar provides practical and conceptual guidance for scientists looking to push the boundaries of metabolomics and lipidomics research using modern analytical platforms such as timsMetabo™.
This broadcast is designed for:
- Scientists using mass spectrometry in metabolomics, lipidomics, and small‑molecule analysis
- Researchers in clinical, translational, biopharmaceutical, and toxicology settings
- Teams working in biomarker discovery, exposomics, and pathway analysis
- Lab leaders evaluating next‑generation MS and ion mobility platforms
Speaker: Dr. Michael Witting (Deputy Head Metabolomics and Proteomics Core & Executive Manager Metabolomics, Helmholtz Munich)
Speaker: Prof. Pieter Dorrestein (Skaggs School of Pharmacy and Pharmaceutical Sciences, Departments of Pharmacology and Pediatrics)
Speaker: Pelle Simpson (Principal Scientist, Enveda)
Moderator: Cameron Smith-Craig (Pharma and Applied Sciences Editor, SelectScience)
